Sign in
4

Changes in Ownership

IRulya Therapeutics Inc. Filed Acc 0001209191-22-031503

Director acquired 519,283 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Low Philip S Director 2022-05-19 Grant or award +455,309 455,309 D
Low Philip S Director 2022-05-19 Grant or award +63,974 63,974 I
Derivatives
Low Philip S Director 2022-05-19 Grant or award · Stock Option (right to buy) +22,058 22,058 D
Loading xslF345X03/doc4.xml…